The pancreatic beta cell as a paradigm for advances in inositide research

Christopher J. Barker, Per Olof Berggren

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In a previous review for Advances in Enzyme Research (Berggren and Barker, 2008) we outlined the history of our involvement in discovering important roles for inositides in the insulin secreting pancreatic beta cell. In this current appraisal we bring the work up to date and project how we believe this field will continue to develop in the future. Recently, we have seen an important synergism between the growth in our understanding of inositide function and our knowledge of beta cell stimulus-secretion coupling in both physiological and pathophysiological contexts. Important advances have been made in three areas. 1. The classic regulation of cytoplasmic free Ca2+ concentration [Ca2+]i by Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and its receptor, 2. A novel role of the inositol pyrophosphates, especially 5-diphosphoinositol pentakisphosphate (5-PP-InsP5), in exocytosis, and 3. The unique signaling roles of PI3K pathways instituted by the engagement of the insulin receptor in an autocrine, positive feed-back loop. We examine each of these in turn and close with an assessment of the likely future directions the research will take.

Original languageEnglish
Pages (from-to)361-368
Number of pages8
JournalAdvances in Biological Regulation
Volume52
Issue number3
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

Fingerprint

Insulin-Secreting Cells
Inositol 1,4,5-Trisphosphate
Diphosphates
Insulin Receptor
Exocytosis
Inositol
Phosphatidylinositol 3-Kinases
Research
History
Enzymes
Growth
1-diphosphoinositol pentakisphosphate
Direction compound
inositol pentaphosphate

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology
  • Molecular Medicine

Cite this

The pancreatic beta cell as a paradigm for advances in inositide research. / Barker, Christopher J.; Berggren, Per Olof.

In: Advances in Biological Regulation, Vol. 52, No. 3, 01.09.2012, p. 361-368.

Research output: Contribution to journalArticle

Barker, Christopher J. ; Berggren, Per Olof. / The pancreatic beta cell as a paradigm for advances in inositide research. In: Advances in Biological Regulation. 2012 ; Vol. 52, No. 3. pp. 361-368.
@article{6933479ffe8e4953882b8dbd525db3fb,
title = "The pancreatic beta cell as a paradigm for advances in inositide research",
abstract = "In a previous review for Advances in Enzyme Research (Berggren and Barker, 2008) we outlined the history of our involvement in discovering important roles for inositides in the insulin secreting pancreatic beta cell. In this current appraisal we bring the work up to date and project how we believe this field will continue to develop in the future. Recently, we have seen an important synergism between the growth in our understanding of inositide function and our knowledge of beta cell stimulus-secretion coupling in both physiological and pathophysiological contexts. Important advances have been made in three areas. 1. The classic regulation of cytoplasmic free Ca2+ concentration [Ca2+]i by Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and its receptor, 2. A novel role of the inositol pyrophosphates, especially 5-diphosphoinositol pentakisphosphate (5-PP-InsP5), in exocytosis, and 3. The unique signaling roles of PI3K pathways instituted by the engagement of the insulin receptor in an autocrine, positive feed-back loop. We examine each of these in turn and close with an assessment of the likely future directions the research will take.",
author = "Barker, {Christopher J.} and Berggren, {Per Olof}",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.jbior.2012.05.002",
language = "English",
volume = "52",
pages = "361--368",
journal = "Advances in Biological Regulation",
issn = "2212-4926",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - The pancreatic beta cell as a paradigm for advances in inositide research

AU - Barker, Christopher J.

AU - Berggren, Per Olof

PY - 2012/9/1

Y1 - 2012/9/1

N2 - In a previous review for Advances in Enzyme Research (Berggren and Barker, 2008) we outlined the history of our involvement in discovering important roles for inositides in the insulin secreting pancreatic beta cell. In this current appraisal we bring the work up to date and project how we believe this field will continue to develop in the future. Recently, we have seen an important synergism between the growth in our understanding of inositide function and our knowledge of beta cell stimulus-secretion coupling in both physiological and pathophysiological contexts. Important advances have been made in three areas. 1. The classic regulation of cytoplasmic free Ca2+ concentration [Ca2+]i by Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and its receptor, 2. A novel role of the inositol pyrophosphates, especially 5-diphosphoinositol pentakisphosphate (5-PP-InsP5), in exocytosis, and 3. The unique signaling roles of PI3K pathways instituted by the engagement of the insulin receptor in an autocrine, positive feed-back loop. We examine each of these in turn and close with an assessment of the likely future directions the research will take.

AB - In a previous review for Advances in Enzyme Research (Berggren and Barker, 2008) we outlined the history of our involvement in discovering important roles for inositides in the insulin secreting pancreatic beta cell. In this current appraisal we bring the work up to date and project how we believe this field will continue to develop in the future. Recently, we have seen an important synergism between the growth in our understanding of inositide function and our knowledge of beta cell stimulus-secretion coupling in both physiological and pathophysiological contexts. Important advances have been made in three areas. 1. The classic regulation of cytoplasmic free Ca2+ concentration [Ca2+]i by Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and its receptor, 2. A novel role of the inositol pyrophosphates, especially 5-diphosphoinositol pentakisphosphate (5-PP-InsP5), in exocytosis, and 3. The unique signaling roles of PI3K pathways instituted by the engagement of the insulin receptor in an autocrine, positive feed-back loop. We examine each of these in turn and close with an assessment of the likely future directions the research will take.

UR - http://www.scopus.com/inward/record.url?scp=84864571029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864571029&partnerID=8YFLogxK

U2 - 10.1016/j.jbior.2012.05.002

DO - 10.1016/j.jbior.2012.05.002

M3 - Article

VL - 52

SP - 361

EP - 368

JO - Advances in Biological Regulation

JF - Advances in Biological Regulation

SN - 2212-4926

IS - 3

ER -